US FDA Opioids Adcomm Postponed; Are Communications Freeze, Travel Ban To Blame?

 
• By Sue Sutter
  
Meeting postponed sign
US FDA has postponed, without explanation, an advisory committee meeting on opioid postmarketing studies. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US Advisory Committees

More from Product Reviews